Close Menu

NEW YORK – BioMérieux announced Tuesday evening that its Vidas TB-IGRA (interferon gamma release assay) has been CE marked for the diagnosis of latent TB infection.

The fully automated assay is to help in the diagnosis of Mycobacterium tuberculosis infection and is for use on BioMérieux's Vidas 3 platform. The test is fully automated from sample to result interpretation and requires one whole-blood sample tube with no manual sample preparation necessary, the Marcy L'Etoile, France-based company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.